Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1679-1689

  Singh, Surinder M ^a   Hutchings, Regina L ^a   Mallela, Krishna M G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antimicrobial preservative; Cresol; Cytochrome c; Formulation; Physical stability; Protein aggregation; Protein structure; Protein unfolding; Proteins; Spectroscopy

Indexed keywords

CYTOCHROME C; META CRESOL; METHIONINE;

ARTICLE; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; TEMPERATURE; UNFOLDED PROTEIN RESPONSE;

EID: 79952239062     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22426     Document Type: Article

References (59)

1. Meyer BK, Ni A, Hu B, Shi L. 2007. Antimicrobial preservative use in parenteral products: Past and present. J Pharm Sci 96:3155-3167.
2. Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations-A close look at protein aggregation, deamidation and oxidation. Crit Rev Ther Drug Carrier Syst 10:307-377
3. Akers MJ. 1984. Considerations in selecting antimicrobial agents for parental product development. Pharm Technol 8:36-46.
4. Akers MJ. 2002. Excipient-drug interactions in parental formulations. J Pharm Sci 91:2283-2300.
5. Jorgensen JT, Mortensen HB, Jorgensen JO. 1991. Patient acceptance of Nordiject: A new drug delivery system for growth hormone. DICP: Annals Pharmacother 25:585-588.
6. Batorova A, Martinowitz U. 2002. Continuous infusion of coagulation factors. Haemophilia 8:170-177.
7. Tan EL, Shah HS, Leister KJ, Kozick LM, Pasciak P, Vanderlaan RK, Yu CD, Patel B. 1993. Transforming growth factor-alpha (TGF-alpha) in a semisolid dosage form: Preservative and vehicle selection. Pharm Res 10:1238-1242.
8. Akers MJ, Vasudevan V, Stickelmeyer M. 2002. Formulation development of protein dosage forms. In Development and manufacture of protein pharmaceuticals; Nail SL, Akers MJ, Eds. New York: Kluwer Academic/ Plenum Publishers, pp 47-127.
9. Maa YF, Hsu CC. 1996. Aggregation of recombinant human growth hormone induced by phenolic compounds. Int J Pharm 140:155-168.
10. Katakam M, Banga AK. 1997. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm Dev Technol 2:143-149.
11. Remmele Jr. RL, Nightlinger NS, Srinivasan S, Gombotz WR. 1998. Interleukin-1 receptor (IL-1RA) liquid formulation development using differential scanning calorimetry. Pharm Res 15:200-208.
12. Gupta S, Kaisheva E. 2003. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. AAPS Pharm Sci 5:1-9.
13. Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20:1325-1336.
14. Moore WV, Leppert P. 1980. Role of aggregated human growth hormone (Hgh) in development of antibodies to Hgh. J Clin Endocrin Metab 51:691-697.
15. Ratner RE, Phillips TM, Steiner M. 1990. Persistent cutaneous insulin allergy resulting from high molecular weight insulin aggregates. Diabetes 39:728-733.
16. Thornton CA, Ballow M. 1993. Safety of intravenous immunoglobulin. Arch Neurol 50:135-136.
17. Fradkin AH, Carpenter JF, Randolph TW. 2009. Immunogenicity of aggregates of recombinant human growth hormone in mouse models. J Pharm Sci 98:3247-3264.
18. Lam XM, Patapoff TW, Nguyen TH. 1997. The effect of benzyl alcohol on recombinant human interferon-γ. Pharm Res 14:725-729.
19. Zhang Y, Roy S, Jones LS, Krishnan S, Kerwin BA, Chang BS, Manning MC, Randolph TW, Carpenter JF. 2004. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1-receptor antagonist in aqueous solution. J Pharm Sci 93:3076-3089.
20. Tobler SA, Holmes BW, Cromwell MEM, Fernandez EJ. 2004. Benzyl alcohol-induced destabilization of interferon-γ. J Pharm Sci 93:1605-1617
21. Roy S, Katayama D, Dong A, Kerwin BA, Randolph TW, Carpenter JF. 2006. Temperature dependence of benzyl alcohol-and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist. Biochemistry 45:3898-3911.
22. Kraulis PJ. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:945-949.
23. Krishna MMG, Lin Y, Mayne L, Englander SW. 2003. Intimate view of a kinetic protein folding intermediate: Residue-resolved structure, interactions, stability, folding and unfolding rates, homogeneity. J Mol Biol 334:501-513.
24. Mayne L, Englander SW. 2000. Two-state vs. multistate protein unfolding studies by optical melting and hydrogen exchange. Protein Sci 9:1873-1877.
25. Sanchez KM, Schlamadinger DE, Gable JE, Kim JE. 2008. Förster resonance energy transfer and conformational stability of proteins. An advanced biophysical module for physical chemistry students. J Chem Ed 85:1253-1256.
26. Banci L, Bertini I, Gray HB, Luchinat C, Reddig T, Rosato A, Turano P. 1997. Solution structure of oxidized horse heart cytochrome c. Biochemistry 36:9867-9877.
27. Feng Y, Roder H, Englander SW, Wand AJ, Stefano DLD. 1989. Proton resonance assignments of horse ferricytochrome c. Biochemistry 28:195-203.
28. Margoliash E, Frohwirt N. 1959. Spectrum of horse-heart cytochrome c. Biochem J 71:570-572.
29. Bowler BE, May K, Zaragoza T, York P, Dong A, Caughey WS. 1993. Destabilizing effects of replacing a surface lysine of cytochrome c with aromatic amino acids: Implications for the denatured state. Biochemistry 32:183-190.
30. Pace CN. 1986. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 131:266-280.
31. Santoro MM, Bolen DW. 1988. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry 27:8063-8068.
32. Santoro MM, Bolen DW. 1992. A test of the linear extrapolation of unfolding free energy changes over an extended denaturant concentration range. Biochemistry 31:4901-4907.
33. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277-293.
34. Lakowicz JR. 2006. Principles of fluorescence spectroscopy. 3rd ed.New York: Springer Science.
35. Milne JS, Xu Y, Mayne LC, Englander SW. 1999. Experimental study of the protein folding landscape: Unfolding reactions in cytochrome c. J Mol Biol 290:811-822.
36. Englander SW, Sosnick TR, Mayne LC, Shtilerman M, Qi PX, Bai Y. 1998. Fast and slow folding in cytochrome c. Acc Chem Res 31:737-744.
37. Dong A, Huang P, Caughey WS. 1990. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29:3303-3308.
38. Barth A. 2000. The infrared absorption of amino acid side chains. Prog Biophys Mol Biol 74:141-173.
39. Myers JK, Pace CN, Scholtz JM. 1995. Denaturant m values and heat capacity changes: Relation to changes in accessible surface areas of protein unfolding. Protein Sci 4:2138-2148.
40. Xu Y, Mayne L, Englander SW. 1998. Evidence for an unfolding and refolding pathway in cytochrome c. Nature Struct Biol 5:774-778.
41. Krishna MMG, Maity H, Rumbley JN, Lin Y, Englander SW. 2006. Order of steps in the cytochrome c folding pathway: Evidence for a sequential stabilization mechanism. J Mol Biol 359:1411-1420.
42. Dong A, Matsuura J, Manning MC, Carpenter JF. 1998. Intermolecular β-sheet results from trifluoroethanol-induced nonnative α-helical structure in β-sheet predominant proteins: Infrared and circular dichroism spectroscopic study. Arch Biochem Biophys 355:275-281.
43. 1-proteinase inhibitor and ovalbumin in aqueous solution. Arch Biochem Biophys 383:148-155.
44. Dong A, Randolph TW, Carpenter JF. 2000. Entrapping intermediates of thermal aggregation in α-helical proteins with low concentration of guanidine hydrochloride. J Biol Chem 275:27689-27693.
45. Margoliash E. 1963. Primary structure and evolution of cytochrome c. Proc Natl Acad Sci USA 50:672-679.
46. Bai Y, Sosnick TR, Mayne L, Englander SW. 1995. Protein folding intermediates: Native-state hydrogen exchange. Science 269:192-197.
47. Maity H, Maity M, Krishna MMG, Mayne L, Englander SW. 2005. Protein folding: The stepwise assembly of foldon units. Proc Natl Acad Sci USA 102:4741-4746.
48. Englander SW, Mayne L, Krishna MMG. 2007. Protein folding and misfolding: Mechanism and principles. Q Rev Biophys 40:287-326.
49. Hoang L, Bédard S, Krishna MMG, Lin Y, Englander SW. 2002. Cytochrome c folding pathway: Kinetic native-state hydrogen exchange. Proc Natl Acad Sci USA 99:12173-12178.
50. Krishna MMG, Lin Y, Rumbley JN, Englander SW. 2003. Cooperative omega loops in cytochrome c: Role in folding and function. J Mol Biol 331:29-36.
51. Hagihara Y, Tan Y, Goto Y. 1994. Comparison of the conformational stability of the molten globule and native states of horse cytochrome c: Effects of acetylation, urea and guanidine-hydrochloride. J Mol Biol 237:336-348.
52. 2O. Biochemistry 32:11878-11885.
53. Sinibaldi F, Howes BD, Smulevich G, Ciaccio C, Coletta M, Santucci R. 2003. Anion concentration modulates the conformation and stability of the molten globule of cytochrome c. J Biol Inorg Chem 8:663-670.
54. Pinheiro TJT, Elove GA, Watts A, Roder H. 1997. Structural and kinetic description of cytochrome c unfolding induced by the interaction with lipid vesicles. Biochemistry 36:13122-13132.
55. Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. 2006. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci 95:1480-1497.
56. Singh SM, Cabello-Villegas J, Hutchings RL, Mallela KMG. 2010. Role of partial protein unfolding in alcohol-induced protein aggregation. Proteins: Struct Funct Bioinform 78:2625-2637.
57. O'Neil MJ. The Merck Index - An encyclopedia of chemicals, drugs, and biologicals 14th ed. Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA.
58. Huus K, Havelund S, Olsen HB, Sigurskjold BW, van de Weert M, Frokjaer S. 2006. Ligand binding and thermostability of different allosteric states of the insulin zinc-hexamer. Biochemistry 45:4014-4024.
59. Goyal MK, Roy I, Amin A, Banerjee UC, Bansal AK. 2010. Stabilization of lysozyme by benzyl alcohol: Surface tension and thermodynamic parameters. J Pharm Sci 99:4149-4161.